186 related articles for article (PubMed ID: 38102698)
1. CSF-1R inhibitor PLX3397 attenuates peripheral and brain chronic GVHD and improves functional outcomes in mice.
Shaikh SN; Willis EF; Dierich M; Xu Y; Stuart SJS; Gobe GC; Bashaw AA; Rawashdeh O; Kim SJ; Vukovic J
J Neuroinflammation; 2023 Dec; 20(1):300. PubMed ID: 38102698
[TBL] [Abstract][Full Text] [Related]
2. Extracorporeal photophoresis: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2006; 6(6):1-82. PubMed ID: 23074497
[TBL] [Abstract][Full Text] [Related]
3. CSF-1-dependant donor-derived macrophages mediate chronic graft-versus-host disease.
Alexander KA; Flynn R; Lineburg KE; Kuns RD; Teal BE; Olver SD; Lor M; Raffelt NC; Koyama M; Leveque L; Le Texier L; Melino M; Markey KA; Varelias A; Engwerda C; Serody JS; Janela B; Ginhoux F; Clouston AD; Blazar BR; Hill GR; MacDonald KP
J Clin Invest; 2014 Oct; 124(10):4266-80. PubMed ID: 25157821
[TBL] [Abstract][Full Text] [Related]
4. Mesenchymal stromal cells as treatment or prophylaxis for acute or chronic graft-versus-host disease in haematopoietic stem cell transplant (HSCT) recipients with a haematological condition.
Fisher SA; Cutler A; Doree C; Brunskill SJ; Stanworth SJ; Navarrete C; Girdlestone J
Cochrane Database Syst Rev; 2019 Jan; 1(1):CD009768. PubMed ID: 30697701
[TBL] [Abstract][Full Text] [Related]
5. Ex Vivo Generated Human Cord Blood Myeloid-Derived Suppressor Cells Attenuate Murine Chronic Graft-versus-Host Diseases.
Lim JY; Ryu DB; Park MY; Lee SE; Park G; Kim TG; Min CK
Biol Blood Marrow Transplant; 2018 Dec; 24(12):2381-2396. PubMed ID: 30006304
[TBL] [Abstract][Full Text] [Related]
6. B cells in chronic graft-versus-host disease.
McManigle W; Youssef A; Sarantopoulos S
Hum Immunol; 2019 Jun; 80(6):393-399. PubMed ID: 30849450
[TBL] [Abstract][Full Text] [Related]
7. [Regulation of colony-stimulating factor 1 receptor inhibitor pexidartinib on the senescence of mouse bone marrow-derived macrophages stimulated by lipopolysaccharide].
Xiao TJ; Zhang J; Kang JB; Li L; Zhan JF; Wei Y; Tian A
Zhonghua Kou Qiang Yi Xue Za Zhi; 2023 Jun; 58(6):575-583. PubMed ID: 37272003
[No Abstract] [Full Text] [Related]
8. Humanized Chronic Graft-versus-Host Disease in NOD-SCID il2rγ-/- (NSG) Mice with G-CSF-Mobilized Peripheral Blood Mononuclear Cells following Cyclophosphamide and Total Body Irradiation.
Fujii H; Luo ZJ; Kim HJ; Newbigging S; Gassas A; Keating A; Egeler RM
PLoS One; 2015; 10(7):e0133216. PubMed ID: 26176698
[TBL] [Abstract][Full Text] [Related]
9. Donor bone marrow-derived macrophage MHC II drives neuroinflammation and altered behavior during chronic GVHD in mice.
Adams RC; Carter-Cusack D; Shaikh SN; Llanes GT; Johnston RL; Quaife-Ryan G; Boyle G; Koufariotis LT; Möller A; Blazar BR; Vukovic J; MacDonald KPA
Blood; 2022 Mar; 139(9):1389-1408. PubMed ID: 34570880
[TBL] [Abstract][Full Text] [Related]
10. Superior GVHD-free, relapse-free survival for G-BM to G-PBSC grafts is associated with higher MDSCs content in allografting for patients with acute leukemia.
Fan Q; Liu H; Liang X; Yang T; Fan Z; Huang F; Ling Y; Liao X; Xuan L; Xu N; Xu X; Ye J; Liu Q
J Hematol Oncol; 2017 Jul; 10(1):135. PubMed ID: 28676100
[TBL] [Abstract][Full Text] [Related]
11. CCL1 blockade alleviates human mesenchymal stem cell (hMSC)-induced pulmonary fibrosis in a murine sclerodermatous graft-versus-host disease (Scl-GVHD) model.
Lim JY; Ryu DB; Kim TW; Lee SE; Park G; Yoon HK; Min CK
Stem Cell Res Ther; 2020 Jun; 11(1):254. PubMed ID: 32586381
[TBL] [Abstract][Full Text] [Related]
12. [Treatment of secondary engraftment failure with granulocyte colony-stimulating factor and eltrombopag after allogeneic peripheral blood stem cell transplantation in adult T-cell leukemia/lymphoma].
Kiyohara K; Sugawara N; Maeta T; Miyajima S; Takano M; Nishiya M; Nishiya M; Sasaki R; Okano Y; Kamihara S; Kowata S; Oyake T; Ito S
Rinsho Ketsueki; 2021; 62(10):1499-1504. PubMed ID: 34732623
[TBL] [Abstract][Full Text] [Related]
13. Positive Effects of Oral Antibiotic Administration in Murine Chronic Graft-Versus-Host Disease.
Sato S; Shimizu E; He J; Ogawa M; Asai K; Yazu H; Rusch R; Yamane M; Yang F; Fukuda S; Kawakami Y; Tsubota K; Ogawa Y
Int J Mol Sci; 2021 Apr; 22(7):. PubMed ID: 33916809
[TBL] [Abstract][Full Text] [Related]
14. Risk Factors and Outcome of Chronic Graft-versus-Host Disease after Allogeneic Stem Cell Transplantation-Results from a Single-Center Observational Study.
Grube M; Holler E; Weber D; Holler B; Herr W; Wolff D
Biol Blood Marrow Transplant; 2016 Oct; 22(10):1781-1791. PubMed ID: 27343720
[TBL] [Abstract][Full Text] [Related]
15. Targeting Bcl-6 prevents sclerodermatous chronic graft-versus-host disease by abrogating T follicular helper differentiation in mice.
Chen X; Wang Y; Huang X; Geng S; Li C; Zeng L; Huang L; Du X; Weng J; Lai P
Int Immunopharmacol; 2023 Apr; 117():109746. PubMed ID: 36827923
[TBL] [Abstract][Full Text] [Related]
16. Bone marrow versus peripheral blood allogeneic haematopoietic stem cell transplantation for haematological malignancies in adults.
Holtick U; Albrecht M; Chemnitz JM; Theurich S; Skoetz N; Scheid C; von Bergwelt-Baildon M
Cochrane Database Syst Rev; 2014 Apr; 2014(4):CD010189. PubMed ID: 24748537
[TBL] [Abstract][Full Text] [Related]
17. GM-CSF therapy inhibits chronic graft-versus-host disease via expansion of regulatory T cells.
Hotta M; Yoshimura H; Satake A; Tsubokura Y; Ito T; Nomura S
Eur J Immunol; 2019 Jan; 49(1):179-191. PubMed ID: 30457669
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic potential of tranilast for the treatment of chronic graft-versus-host disease in mice.
Mukai S; Ogawa Y; Saya H; Kawakami Y; Tsubota K
PLoS One; 2018; 13(10):e0203742. PubMed ID: 30307955
[TBL] [Abstract][Full Text] [Related]
19. Prognostic factors of chronic graft-versus-host disease after allogeneic blood stem-cell transplantation.
Pavletic SZ; Smith LM; Bishop MR; Lynch JC; Tarantolo SR; Vose JM; Bierman PJ; Hadi A; Armitage JO; Kessinger A
Am J Hematol; 2005 Apr; 78(4):265-74. PubMed ID: 15795914
[TBL] [Abstract][Full Text] [Related]
20. Chronic graft-versus-host disease in children: incidence, risk factors, and impact on outcome.
Zecca M; Prete A; Rondelli R; Lanino E; Balduzzi A; Messina C; Fagioli F; Porta F; Favre C; Pession A; Locatelli F;
Blood; 2002 Aug; 100(4):1192-200. PubMed ID: 12149197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]